Website privacy draft

This document is a prelaunch website-only draft pending legal approval. It is not an effective privacy notice and should not be treated as a final statement of ClinicPro360 practices. It is published so early evaluators can understand the intended boundary of the public marketing website while launch review is underway.

The draft covers business visitors who browse clinicpro360.com or submit its product-interest form. It does not cover a ClinicPro360 application, patient portal, clinical record, payment service, telehealth session, customer workspace, or any other product service. Those services are not offered under this draft and will require separate, approved notices and agreements before launch.

This is not a HIPAA Notice of Privacy Practices. Do not use this website to send protected health information or to request care, clinical advice, or emergency assistance.

The walkthrough form currently asks for business contact and practice-level information: first and last name, work email, optional phone number, practice name, role, approximate practice size, consent to contact, the source page, and campaign parameters that may appear in the link used to reach the form. A hidden anti-spam field may also be submitted.

Normal website delivery may generate technical information such as an IP address, browser and device details, requested pages, timestamps, referrer information, and security or error events. The exact hosting, monitoring, analytics, retention, and cookie configuration remains subject to production review. This draft does not state that optional analytics or advertising tools are active.

ClinicPro360 does not ask for patient or clinical information through the marketing website. Visitors should not submit patient names, appointments, diagnoses, treatment information, insurance information, record identifiers, or other protected health information.

The intended uses are to receive and respond to a product-interest request, understand the business context of an evaluation, maintain the security and reliability of the public website, prevent abuse, and improve prelaunch planning. Any additional marketing use, preference management, analytics purpose, or disclosure practice must be reviewed and described in an approved notice before it is relied upon.

Submitting the form does not create a customer, patient, provider, or clinical relationship. It does not authorize the transfer of health records or establish that ClinicPro360 is ready to receive protected health information.

The public website may rely on infrastructure, hosting, security, communications, and form-processing providers. The final provider list and data-flow record must be confirmed against the production environment before an effective notice is approved.

The approved notice will need to explain the circumstances in which business information may be handled by providers, disclosed for security or legal process, or involved in a business transaction. This draft does not create broader disclosure rights or make a representation about an unreviewed vendor arrangement.

Production retention periods, deletion procedures, backup behavior, access controls, and hosting locations remain launch-gate items. The final notice should reflect verified configuration and approved policy rather than assumptions. No retention period or deletion guarantee is made by this draft.

No internet transmission or storage system can be described as risk-free. Production security statements will be limited to controls that have been configured, tested, and supported by current evidence. Visitors can reduce risk by keeping submissions to the requested business fields and excluding patient information.

Applicable privacy rights differ by location and circumstance. A final process for access, correction, deletion, consent withdrawal, and other requests must be approved before launch. For questions about this website draft or business contact information already submitted, email hello@clinicpro360.com. Do not include patient information in that message.

The final notice will identify any verification steps, authorized-agent process, appeal method, jurisdiction-specific disclosures, and response requirements that apply. This draft does not waive or limit rights provided by law.

This draft is dated July 11, 2026 for prelaunch review. It has not been approved as an effective privacy notice. Before launch, counsel and the responsible business and security owners must review the live data flow, provider inventory, cookies and storage, form delivery, retention rules, request process, and product boundaries.

When an approved notice becomes effective, the website should identify its effective date and replace this draft. Material product privacy obligations should be addressed in separate customer, patient-facing, and regulated-service materials as applicable.